Modulating the activity of oligonucleotides by carbohydrate conjugation: Solid phase synthesis of sucrose-oligonucleotide hybrids

Organic and Biomolecular Chemistry

Volumn 2, Issue 13, 2004, Pages 1879-1886

  Adinolfi, Matteo ^a   De Napoli, Lorenzo ^a   Fabio, Giovanni Di ^a   Iadonisi, Alfonso ^a   Montesarchio, Daniela ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATES; DERIVATIVES; ENZYMES; MODULATION; MOLECULAR STRUCTURE; STABILITY; SYNTHESIS (CHEMICAL);

ENZYMATIC STABILITY; HYBRIDS; OLIGONUCLEOTIDES;

OLIGOMERS;

OLIGONUCLEOTIDE; SUCROSE;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; CIRCULAR DICHROISM; CONFORMATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SYNTHESIS;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CIRCULAR DICHROISM; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR STRUCTURE; NUCLEIC ACID CONFORMATION; OLIGONUCLEOTIDES; SUCROSE;

EID: 3142663253     PISSN: 14770520     EISSN: None     Source Type: Journal    
DOI: 10.1039/b401819b     Document Type: Article

References (36)

1. E. Uhlmann and A. Peyman, Chem. Rev., 1990, 90, 543-584.
2. N. T. Thuong and C. Hélène, Angew. Chem., Int. Ed. Engl. 1993, 32, 666-690.
3. M. Famulok, G. Mayer and M. Blind, Acc. Chem. Res., 2000, 33, 591-599.
4. Y. S. Sanghvi, in Carbohydrate Modifications in Antisense Research, ed. P. Dan Cook, ACS Symposium Series, Washington, USA, 1994.
5. S. L. Beaucage and R. P. Iyer, Tetrahedron, 1993, 49, 1925-1963.
6. P. Virta, J. Katajisto, T. Niittymaki and H. Lonnberg, Tetrahedron, 2003, 59, 5137-5174.
7. C. F. Brewer, M. C. Miceli and L. G. Baum, Curr. Opin. Struct. Biol., 2002, 12, 616-623.
8. M. W. Turner, Mol. Immunol., 2003, 40, 423-29.
9. H. Kunz, Angew. Chem., Int. Ed. Engl., 1987, 26, 294-308.
10. H. Paulsen, Angew. Chem., Int. Ed Engl., 1990, 29, 823-938.
11. B. G. Davis, Chem. Rev., 2002, 102, 579-601.
12. S. Akhtar, A. Roudledge, R. Patel and J. M. Gardiner, Tetrahedron Lett., 1995, 36, 7333-7336.
13. T. Ren and D. Liu, Tetrahedron Lett., 1999, 40, 7621-7625.
14. T. L. Sheppard, C.-H. Wong and G. F. Joyce, Angew. Chem. Int. Ed., 2000, 39, 3660-3663.
15. D. Forget, R. Renaudet, E. Defrancq and P. Dumy, Tetrahedron Lett., 2001, 42, 7829-7832.
16. M. A. Maier, C. G. Yannopoulos, N. Mohamed, A. Roland, H. Fritz, V. Mohan, G. Just and M. Manoharan, Bioconjugate Chem., 2003, 14, 18-29.
17. M. Dubber and J. M. J. Frechet, Bioconjugate Chem., 2003, 14, 239-246.
18. Y. Wang and T. L. Sheppard, Bioconjugate Chem., 2003, 14, 1314-1322.
19. K. Matsuura, M. Hibino, M. Kataoka, Y. Hayakawa and K. Kobayashi, Tetrahedron Lett., 2000, 41, 7529-7533.
20. K. Matsuura, M. Hibino, Y. Yamada and K. Kobayashi, J. Am. Chem. Soc., 2001, 123, 357-358.
21. S. Sando, K. Matsui, Y. Niinomi, N. Sato and Y. Aoyama, Bioorg. Med. Chem. Lett., 2003, 13, 2633-2636.
22. K. Matsuura, M. Hibino, T. Ikeda, Y. Yamada and K. Kobayashi, Chem. Eur. J., 2004, 10, 352-359.
23. B. G. Davis, J. Chem. Soc., Perkin Trans. 1, 2000, 2137-2160.
24. P. H. Seeberger and W. Haase, Chem. Rev., 2000, 100, 4349-4394.
25. M. Adinolfi, G. Barone, L. De Napoli, L. Guariniello, A. Iadonisi and G. Piccialli, Tetrahedron Lett., 1999, 40, 2607-2610.
26. M. Adinolfi, L. De Napoli, G. Di Fabio, L. Guariniello, A. Iadonisi, A. Messere, D. Montesarchio and G. Piccialli, Synlett, 2001, 6, 745-748.
27. M. Adinolfi, L. De Napoli, G. Di Fabio, A. Iadonisi, D. Montesarchio and G. Piccialli, Tetrahedron, 2002, 58, 6697-6704.
28. N. Murakami, S. Tamura, E. Iwata, S. Aoki, S. Akiyama and M. Kobayashi, Bioorg. Med. Chem. Lett., 2002, 12, 3267-3270.
29. Oligonucleotides and Analogues: a Practical Approach, ed. F. Eckstein, IRL Press, Oxford, 1991.
30. S. M. Kerwin, Curr. Pharm. Des., 2000, 6, 441-471.
31. M. A. Keniry, Biopolymers, 2001, 56, 123-146.
32. R. Jin, B. L. Gaffney, C. Wang, R. A. Jones and K. J. Breslauer, Proc. Natl. Acad. Sci. USA, 1992, 89, 8832-8836.
33. H. Hotoda, M. Koizumi, R. Koga, M. Kaneko, K. Momota, T. Ohmine, H. Furukawa, T. Agatsuma, T. Nishigaki, J. Sone, S. Tsutsumi, T. Kosaka, K. Abe, S. Kimura and K. Shimada, J. Med. Chem., 1998, 41, 3655-3663.
34. This ODN sequence is complementary to a tract of mRNA of protein kinase A type 1 (PKA1), subunit RIα, overexpressed in the majority of human cancers and well recognized as a relevant target for therapeutic intervention against neoplasia; therefore several modifications of this sequence have been designed for antisense experiments and are currently under clinical trial. See for example: G. Tortora, R. Bianco, V. Damiano, G. Fontanini, S. De Placido, R. Bianco and F. Ciardiello, Clin. Cancer Res., 2000, 6, 2506-2512.
35. R. Khan, Carbohydr. Res., 1974, 32, 375-379.
36. rd edn., CRC Press, 1975, p. 589.